Learn more about Peter Attia’s digital program
The straight dope on cholesterol – Part VII
In this post we’ll address the following concept: Does “HDL” matter after all?
The straight dope on cholesterol – Part III
In this post we’ll address the following concept: How do we measure cholesterol?
#19 – Dave Feldman: stress testing the lipid energy model
“I am on a journey of science, not of advocacy: I’m going to be quite a skeptic.” —Dave Feldman
The straight dope on cholesterol – Part II
In this post we’ll address the following concept: How does cholesterol move around our body?
#129 – Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
“Atherogenic lipoproteins are really the issue behind clinical atherosclerotic vascular disease. … The data has just become so overwhelming.” —Tom Dayspring
#20 – Tom Dayspring, M.D., FACP, FNLA – Part I of V: an introduction to lipidology
“Illustrating things made me understand . . . I just learned by illustrating.” –Tom Dayspring
#111 – AMA #14: What lab tests can (and cannot) inform us about our overall objective of longevity
“Metabolic health really matters. It is the common thread that links all of these chronic diseases.” — Peter Attia
The straight dope on cholesterol – Part V
In this post we’ll address the following concept: Does the size of an LDL particle matter?
The straight dope on cholesterol – Part IV
In this post we’ll address the following concept: How does cholesterol actually cause problems?
Does low cholesterol cause cognitive impairment? Part I
Safety of lipid-lowering therapy